It seems the problem is it lowers blood pressure too and the concern has to do with using too much with PD patients already battling low blood-pressure.
Written by
Coblrman
To view profiles and participate in discussions please or .
"Parkinson's Disease news breaks that a drug that could stop or slow Parkinson’s disease (PD) is advancing in clinical testing.
, the drug isradipine is proceeding to Phase III testing, the last step before regulatory approval. With a $23 million grant from the National Institutes of Health, researchers will test if isradipine has an effect on PD progression. Previous studies showed drugs in the same class, calcium channel blockers, were associated with lower incidence of PD.
When recruitment for this study begins later this year, it will be the most advanced, current trial of a disease-modifying therapy for PD."
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.